Global Pulmonary Drug Delivery Market is Estimated to Reach $52.9 Billion by 2025, Says Accurize Market Research
Global pulmonary drug delivery market report published by Accurize Market Research forecast that the global market is expected to reach $52.9 billion by 2025; growing at a CAGR of 6.6% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
To browse the complete report, visit at https://www.accurizemarketresearch.com/report/pulmonary-drug-delivery-systems-market
Technological developments in the field of drug delivery and growing demand for new products, changing lifestyle, ease of use and improved facilitiesacross the globe to drive the growth of the market
Technological developments in the field of drug delivery and growing demand for new products, changing lifestyle, ease of use and improved facilitiesfuels the demand for the global pulmonary drug delivery market. Moreover,upsurge in number of public and private organizations also boosts the growth of the market.
The global pulmonary drug delivery market has been bifurcated on the basis of product, application and geography. On the basis of product, it is divided into metered dose inhalers (breath-actuated pressurized inhaler and manually-actuated pressurized inhaler), nebulizers (jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers), and dry powder inhalers (single dose inhalers and multi-dose inhalers). On the basis of distributor segment it is bifurcated into Retail Pharmacies, Hospital Pharmacies, and E-commerce. On the basis of application, the market is segmented into asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), and others.
By geography the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S., Canada and Mexico are covered under North America wherein Europe covers UK, Germany, France, Italy, and others. Asia-Pacific covers China, India, Japan, South Korea, and others. Rest of the World covers South America, Middle East and Africa.
“North America dominated the pulmonary drug delivery devices market during the forecast period”, says accurize
In 2017, North America dominated the pulmonary drug delivery devices market and Asia accounted the second-largest regional market. Moreover, the Asia-Pacific is expected to register the highest CAGR during the forecast period due to the rapid growth of geriatric population, growing acceptance of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals and the successive increase in the prevalence of COPD in the area.
Top players in the market
The key market players include GlaxoSmithKline plc, Novartis AG, Koninklijke Philips N.V., 3M Company, Actelion Pharmaceuticals Ltd, AstraZeneca plc, BoehringerIngelheimGmbh, Clement Clarke International, Briggs Healthcare, and Aerogenamong others.
Head - Sales
Accurize Market Research
K-129, PC COLONY, HANUMAN NAGAR,